Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort

被引:3
|
作者
Van Deutekom, Colinda [1 ]
Geelhoed, Bastiaan [1 ]
Van Munster, Barbara C. [2 ]
Bakker, Stephan J. L. [3 ]
Gansevoort, Ron T. [3 ]
Van Gelder, Isabelle C. [1 ]
Rienstra, Michiel [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands
来源
OPEN HEART | 2023年 / 10卷 / 02期
基金
欧盟地平线“2020”;
关键词
Atrial Fibrillation; EPIDEMIOLOGY; RISK FACTORS; HEART-FAILURE; POPULATION; MORTALITY; OUTCOMES;
D O I
10.1136/openhrt-2023-002315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveAtrial fibrillation (AF) is a condition that occurs in the presence of comorbidities. With the accumulation of comorbidities (multimorbidity), some combinations may more often occur together than others. Information on the impact of clustering of these on incident AF is sparse. We aimed to investigate clustering of cardiovascular and renal comorbidities and study the association between comorbidity clusters and incident AF. MethodsWe used the community-based Prevention of Renal and Vascular ENd-stage Disease (PREVEND) cohort in which 8592 individuals participated. Latent class analysis was performed to assess clustering of 10 cardiovascular and renal comorbidities. ResultsWe excluded individuals with prior AF or missing ECG data, leaving 8265 individuals for analysis (mean age 48.9 & PLUSMN;12.6 years, 50.2% women). During 9.2 & PLUSMN;2.1 years of follow-up, 251 individuals (3.0%) developed AF. A model with three clusters was the optimal model, with one cluster being young (44.5 & PLUSMN;10.8 years) and healthy, carrying a low (1.0%) risk of incident AF; one cluster being older (63.0 & PLUSMN;8.4 years) and multimorbid, carrying a high (16.2%) risk of incident AF and a third middle-aged (57.0 & PLUSMN;11.3 years), obese and hypertensive cluster carrying an intermediate risk (5.9%) of incident AF. While the prevalence of the comorbidities differed between classes, no clear combination(s) of comorbidities was observed within the classes. ConclusionsWe identified three clusters of comorbidities in individuals in the community-based PREVEND cohort. The three clusters contained different amount of comorbidities carrying different risks of incident AF. However, there were no differences between the clusters regarding specific combination(s) of comorbidities.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: data from PREVEND
    Al Mubarak, A. A.
    Beverborg, N. Grote
    Zwartkruis, V.
    Van Deutekom, C.
    De Borst, M. H.
    Gansevoort, R. T.
    Bakker, S. J. L.
    Touw, D. J.
    De Boer, R. A.
    Van der Meer, P.
    Rienstra, M.
    Bomer, N.
    EUROPEAN HEART JOURNAL, 2022, 43 : 519 - 519
  • [22] Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study
    Wu, Jianhua
    Nadarajah, Ramesh
    Nakao, Yoko M.
    Nakao, Kazuhiro
    Hogg, David
    Raveendra, Keerthenan
    Arbel, Ronen
    Haim, Moti
    Zahger, Doron
    Cowan, Campbel
    Gale, Chris P.
    OPEN HEART, 2023, 10 (02):
  • [23] Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: data from PREVEND
    Al-Mubarak, Ali A. A.
    Beverborg, Niels Grote
    Zwartkruis, Victor
    van Deutekom, Colinda
    de Borst, Martin H. H.
    Gansevoort, Ron T. T.
    Bakker, Stephan J. L.
    Touw, Daan J. J.
    de Boer, Rudolf A. A.
    van der Meer, Peter
    Rienstra, Michiel
    Bomer, Nils
    CLINICAL RESEARCH IN CARDIOLOGY, 2025, 114 (01) : 41 - 52
  • [24] Cardiac Microstructural Abnormalities Increase Risk for Atrial Fibrillation
    Demosthenes, Emmanuella
    Salto, Gerran
    Osypiuk, Ewa
    Stantchev, Plamen
    Lehman, Birgitta
    Kim, Elizabeth H.
    Hiremath, Pranoti
    Cheng, Susan
    CIRCULATION, 2019, 140
  • [25] Multimorbidity and comorbidity in atrial fibrillation and effects on survival: findings from UK biobank cohort
    Jani, B.
    Nicholl, B.
    McQueenie, R.
    Connelly, D.
    Hanlon, P.
    Gallacher, K.
    Lee, D.
    Mair, F.
    EUROPEAN HEART JOURNAL, 2017, 38 : 981 - 981
  • [26] Multimorbidity and comorbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort
    Jani, B. D.
    Nicholl, B.
    McQueenie, R.
    Connelly, D.
    Hanlon, P.
    Gallacher, K., I
    Lee, D.
    Mair, F. S.
    INTERNATIONAL JOURNAL OF STROKE, 2017, 12 : 41 - 41
  • [27] Reducing risk of adverse cardiovascular and renal outcomes for patients with atrial fibrillation and type 2 diabetes
    Harrison, Stephanie L.
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (01) : 136 - 138
  • [28] Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations
    Rienstra, Michiel
    Geelhoed, Bastiaan
    Yin, Xiaoyan
    Siland, Joylene E.
    Vermond, Rob A.
    Mulder, Bart A.
    Van Der Harst, Pim
    Hillege, Hans L.
    Benjamin, Emelia J.
    Van Gelder, Isabelle C.
    PLOS ONE, 2016, 11 (11):
  • [29] Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study
    Chamberlain, Alanna M.
    Alonso, Alvaro
    Gersh, Bernard J.
    Manemann, Sheila M.
    Killian, Jill M.
    Weston, Susan A.
    Byrne, Margaret
    Roger, Veronique L.
    AMERICAN HEART JOURNAL, 2017, 185 : 74 - 84
  • [30] Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study
    Menichelli, Danilo
    Sciacqua, Angela
    Cangemi, Roberto
    Andreozzi, Paola
    Del Sole, Francesco
    Violi, Francesco
    Pignatelli, Pasquale
    Pastori, Daniele
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (03)